Enhanced generation of iPSCs from older adult human cells by a synthetic five-factor self-replicative RNA
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We previously devised a polycistronic, synthetic self-replicating RNA (srRNA) to generate human induced Pluripotent Stem Cells (iPSCs) that simultaneously expresses four reprogramming factors (4F). However, while the best 4F srRNA efficiently generated iPSCs from young fibroblasts, it was inefficient on adult human fibroblasts (>50 years). To increase the iPSC generation efficiency, we included additional reprogramming factors. We found that a single transfection of a five factor (5F) srRNA, containing OCT4, KLF4, SOX2, GLIS1 and c-MYC, robustly generated iPSCs from adult human fibroblasts aged 54 to 77 and from a 24 year old cardiomyopathy patient donor. Interestingly, 5F-srRNA induced LIN28A, which was one of the original reprogramming factors. 5F-srRNA also accelerated the generation of iPSCs by seven days compared to 4F-srRNAs. Further improvements include phosphatase treatment to remove 5' phosphate and use of Lipofectamine MessengerMAX that increased transfection efficiency to ~90%. Together, these improvements enabled us to efficiently generate iPSCs from human fibroblasts using 5F-srRNA while eliminating both puromycin selection and feeder cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“implying that a reprogramming method might need optimization to successfully reprogram adult somatic cells.”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“The authors were able to increase the reprogramming efficiency of adult fibroblasts by adding an additional transcription factor to the reprogramming cocktail [3]”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Alphaviral self-replicating RNA is an alternative vector for fast reprogramming, which requires only one transfection.52,53”
From Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening (2019) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
FUSAKI, N., BAN, H., NISHIYAMA, A., SAEKI, K., & HASEGAWA, M. (2009) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.85.348 · Cited by 1,411
The tumorigenicity of human embryonic and induced pluripotent stem cells
Ben-David, U., & Benvenisty, N. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3034 · Cited by 889
Cited by
Orlandini von Niessen, A. G., Poleganov, M. A., Rechner, C., Plaschke, A., Kranz, L. M., Fesser, S., Diken, M., Löwer, M., Vallazza, B., Beissert, T., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.011 · Cited by 365
“Alphaviral self-replicating RNA is an alternative vector for fast reprogramming, which requires only one transfection.(52,53) It, however, comes with the disadvantage that clinical grade iPSCs have to be free of residual contaminations of self-replicating vectors.”
BackgroundJetten, A. M. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2841-9 · Cited by 95
“Moreover, OCT4, KLF4, SOX2, GLIS1 and c-MYC, robustly generated iPSCs from human fibroblasts from older adults, age 54–77 [103].”
Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
Versteeg, L., Almutairi, M. M., Hotez, P. J., & Pollet, J. (2019) · Vaccines · doi:10.3390/vaccines7040122 · Cited by 92
Borgohain, M. P., Haridhasapavalan, K. K., Dey, C., Adhikari, P., & Thummer, R. P. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9861-6 · Cited by 89
Current challenges in three-dimensional bioprinting heart tissues for cardiac surgery
Roche, C. D., Brereton, R. J. L., Ashton, A. W., Jackson, C., & Gentile, C. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa093 · Cited by 65
“However, the advent of iPSCs provides a promising cell source for regeneration, including 3D bioprinting of myocardial tissue [5, 9, 25, 26].”
BackgroundNeutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine
Perche, F., Clemençon, R., Schulze, K., Ebensen, T., Guzmán, C. A., & Pichon, C. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.07.014 · Cited by 55
“Although low, this percentage is in agreement with the 11%–21% DC transfection using lipids(66) and with the 16% pluripotent stem cell transfection using RepRNA GFP.(67) No significant difference in transfection efficiency was observed at 24 h between LPPs and LFM (14% versus 18%, respectively).”
ResultSelf-amplifying mRNA-Based Vaccine Technology and Its Mode of Action
Maruggi, G., Ulmer, J. B., Rappuoli, R., & Yu, D. L. (2021) · Current topics in microbiology and immunology · doi:10.1007/82_2021_233 · Cited by 57
Delivery of synthetic mRNAs for tissue regeneration
Steinle, H., Weber, M., Stoppelkamp, S., Große‐Berkenbusch, K., Golombek, S., Weber, M., Çanak-Ipek, T., Trenz, S.-M., Schlensak, C., & Avci‐Adali, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114007 · Cited by 43
Steinle, H., Weber, M., Behring, A., Mau-Holzmann, U. A., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2019) · Stem Cells International · doi:10.1155/2019/7641767 · Cited by 39
“Furthermore, the use of adult fibroblasts or fibroblasts from diseased patients as well as the use of other somatic cells can result in other reprogramming efficiencies [6, 24, 37].”
BackgroundOvercoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
“The authors were able to increase the re-programming efficiency of adult fibroblasts by adding an additional transcription factor to the reprogramming cocktail [3], implying that a reprogramming method might need optimization to successfully reprogram adult somatic cells.”
BackgroundDey, C., Raina, K., Haridhasapavalan, K. K., Thool, M., Sundaravadivelu, P. K., Adhikari, P., Gogoi, R., & Thummer, R. P. (2021) · Recent Advances in iPSC Technology · doi:10.1016/b978-0-12-822231-7.00011-4 · Cited by 23
Recent advances in the induced pluripotent stem cell‐based skin regeneration
Choudhury, S., Surendran, N., & Das, A. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12925 · Cited by 25
“Since the half-life of RNA is short, the cells need to be repeatedly transfected to maintain the reprogramming process.(28,29) This method of reprogramming has higher efficiency than the other non-integrative delivery systems and can also be used for directed differentiation of cells.”
BackgroundGLIS1-3: Links to Primary Cilium, Reprogramming, Stem Cell Renewal, and Disease
Jetten, A. M., Scoville, D. W., & Kang, H. S. (2022) · Cells · doi:10.3390/cells11111833 · Cited by 17
RNA-Based Strategies for Cell Reprogramming toward Pluripotency
Bailly, A., Milhavet, O., & Lemaître, J.-M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020317 · Cited by 20
Biomaterial aided differentiation and maturation of induced pluripotent stem cells
Velmurugan, B. K., Priya, L. B., Poornima, P., Lee, L., & Baskaran, R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27769 · Cited by 16
“Synthetic self‐replicating RNA induces reprogramming factor LIN28A which increase the iPSC generation efficiency (Rohani et al., 2016; Yoshioka & Dowdy, 2017), recombinant/ purified proteins (F. Chen et al., 2016; Nordin, Ahmad, & Farzaneh, 2017; Zhou et al., 2009), and plasmids (Megges, Oreffo, &…”
BackgroundReprogramming and transdifferentiation - two key processes for regenerative medicine
Hybiak, J., Jankowska, K., Machaj, F., Rosik, J., Broniarek, I., Żyluk, A., Hilderman, G. C., Małecki, A., Łoś, M., & Urasińska, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173202 · Cited by 20
Zika virus NS4B protein targets TANK-binding kinase 1 and inhibits type I interferon production
Sarratea, M. B., Alberti, A. S., Redolfi, D. M., Truant, S. N., López, L. V. I., Bivona, A. E., Mariuzza, R. A., Fernández, M. M., & Malchiodi, E. L. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130483 · Cited by 12
Tanaka, N., Kato, H., Tsuda, H., Sato, Y., Muramatsu, T., Iguchi, A., Nakajima, H., Yoshitake, A., & Senbonmatsu, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186764 · Cited by 13
“from an RNA-replicative vector yielded high-efficiency iPS cell reprogramming from older adult human cells [32].”
BackgroundGeneration and applications of cardiac spheroids
Idais, D., Roche, C. D., Kalogianni, G., Polonchuk, L., & Gentile, C. (2025) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00024-y · Cited by 15
Establishment of fishing cat cell biobanking for sustainable conservation
Sukparangsi, W., Thongphakdee, A., Karoon, S., Ayuthaya, N. S. N., Hengkhunthod, I., Parkongkeaw, R., Bootsri, R., & Sikaeo, W. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.989670 · Cited by 12
Kim, M., Hwang, S., Yoon, J. D., Jeong, Y. W., Kim, E., & Hyun, S. (2020) · Animals · doi:10.3390/ani10101848 · Cited by 10
“for clinical research [26,27,44] due to concerns over the integration of DNA vectors into the genome.”
BackgroundMethodDesign principles and applications of synthetic self‐replicating RNAs
Wagner, A., & Mutschler, H. (2023) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1803 · Cited by 12
“…virus (VEEV) were shown to successfully reprogram both adult human fibroblasts and renal epithelial cells into iPSCs (Steinle, Weber, Behring, Mau-Holzmann, Schlensak, et al., 2019; Steinle, Weber, Beh-ring, Mau-Holzmann, von Ohle, et al., 2019; Yoshioka et al., 2013; Yoshioka & Dowdy, 2017).”
BackgroundGuo, T., Wang, J., Pang, M., Liu, W., Zhang, X., Fan, A., Liu, H., Liu, Q., Wei, T., Li, C., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105534 · Cited by 8
Dey, C., Venkatesan, V., & Thummer, R. P. (2021) · Molecular Biotechnology · doi:10.1007/s12033-021-00390-z · Cited by 7
Bouma, M. J., Arendzen, C. H., Mummery, C. L., Mikkers, H. M. M., & Freund, C. M. A. H. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.124 · Cited by 6
“Here we describe a method to reprogram UDCs with commercially available srRNA containing the reprogramming factors OCT3/4, SOX2, KLF4, c-MYC, and GLIS1 (ReproRNA-OKSGM) (Yoshioka & Dowdy, 2017) with defined media on Matrigel.”
BackgroundMethodDey, C., Raina, K., Thool, M., Adhikari, P., Haridhasapavalan, K. K., Sundaravadivelu, P. K., Venkatesan, V., Gogoi, R., Selvaraju, S., & Thummer, R. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90059-1.00007-5 · Cited by 8
An Insight into the Role of GLIS1 in Embryonic Development, iPSC Generation, and Cancer
Ronima, K. R., Dey, C., & Thummer, R. P. (2023) · Advances in experimental medicine and biology · doi:10.1007/5584_2023_793 · Cited by 3
Keyer, V. V., Shevtsov, A., Zaripov, M. M., Baltabekova, A. Z., Ramanculov, E. M., & Shustov, A. V. (2019) · Journal of Virological Methods · doi:10.1016/j.jviromet.2019.113734 · Cited by 3
Nogueira, I. P. M., dos Santos, R. C. T., Cotta, G. C., Valente, W., Coimbra, J. L. D. P., Ferreira, H. A. S., Guimarães, P. P. G., Santos, A. K., Fontoura, F. M., Ramalho, K. R. D. A., et al. (2025) · Cell Biology International · doi:10.1002/cbin.70089 · Cited by 2
“…for nuclear entry and enable immediate cytosolic translation, an especially attractive feature when working with rare or sensitive cell types (Yoshioka and Dowdy 2017; Hou et al. 2021) Although the derivation of avian iPSCs remains a complex and stepwise endeavor, requiring rigorous…”
Self-replicating RNA for Cellular Reprogramming in Domestic Cat
Sukparangsi, W., Ayuthaya, N. S. N., Prakongkaew, R., Karoon, S., & Thongphakdee, A. (2024) · The Thai Journal of Veterinary Medicine · doi:10.56808/2985-1130.1115 · Cited by 1
Advances in canine iPSC technology: Current methods and future directions — A narrative review
Aruvornlop, P., Chakritbudsabong, W., Sandech, N., Muangthong, T., & Rungarunlert, S. (2025) · Research in Veterinary Science · doi:10.1016/j.rvsc.2025.105844 · Cited by 2
Ortega-Méndez, J., Rojas, J., White, A. C., & Castellanos-González, A. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag302 · Cited by 1
Cardiomyopathy: Recent Findings
Yamada, Y., Sugi, K., Nakajima, H., & Senbonmatsu, T. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97092
Fishing Cat Cell Biobanking for ConservationPreprint
Sukparangsi, W., Thongphakdee, A., Karoon, S., Ayuthaya, N. S. N., Hengkhunthod, I., Parkongkeaw, R., Bootsri, R., & Sikaeo, W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.01.498384
“9 with srRNA using LipofectamineTM MessengerMaxTM (ThermoFisher) according to adjusted Yo232 shioka & Dowdy method [33].”
MethodMultifaceted Role of Induced Pluripotent Stem Cells in Preclinical Cardiac Regeneration Research
Derish, I., & Cecere, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-0846-2_33-1
Multifaceted Role of Induced Pluripotent Stem Cells in Preclinical Cardiac Regeneration Research
Derish, I., & Cecere, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-7119-0_33
Metadata
- Authors
- Yoshioka, N., & Dowdy, S. F.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Dowdy, Steven F.
- ORCID
- Dowdy, Steven F.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-07-27
- Volume
- 12
- Issue
- 7
- Pages
- e0182018
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5531586
- OpenAlex
- W2740231295
- Cited by
- 36
- References
- 26
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 4 · 2018: 4
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Keck Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- induced pluripotent stem cells, reprogramming factors, aging, Oct4, KLF4, SOX2, GLIS1, c-Myc, LIN28A, transfection efficiency, cardiomyopathy
- MeSH terms
- Kruppel-Like Factor 4, Adult, Aged, Animals, Clone Cells, Female, Fibroblasts, Humans, Infant, Newborn, Male, Middle Aged, RNA, Transfection, Cell Culture Techniques, Mice, Young Adult, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.